Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1447782 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1490814 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1529385 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1564713 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1665083 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1713247 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1789052 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1813697 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1920680 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1923656 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1932331 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1937669 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1947948 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1947983 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1978974 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 1999908 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2026256 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2026500 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2034254 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2063668 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2067748 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2071105 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2078077 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2079743 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2084412 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2094162 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2105098 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2114709 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2125303 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2132534 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2165749 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2169200 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2171793 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2173125 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2184157 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2191249 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2193723 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2223226 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2226260 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2228354 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2234882 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2235847 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2238061 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2240160 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2243439 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2256038 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2281924 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2283374 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2283591 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2311217 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2314794 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2329935 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2335523 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2369144 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2379806 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2401273 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2419412 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2419943 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2425832 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2446516 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2448511 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2488022 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2491541 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2497653 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2508460 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2531716 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2533568 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2573247 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2578726 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2593117 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2596010 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2605712 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2622519 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2705807 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2717994 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2736164 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2746039 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2751415 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2773770 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2782676 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2802988 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2818519 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2844981 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2864140 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2871171 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2895611 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2897045 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2952106 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 2972038 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3050464 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3113558 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3118327 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3173099 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3269963 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3287453 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3517766 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3528709 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3587423 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3873913 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LINOLEATE (CAS# 60-33-3); (M-H)- | 3886212 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |